BamSEC and AlphaSense Join Forces
Learn More

Sophiris Bio Inc.

Formerly NASDAQ: SPHS
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 18 pages Series a Common Share Purchase Warrant Sophiris Bio Inc. Warrant Shares: Initial Exercise Date: ___, 2020 Issue Date: ___, 2019
12/34/56
EX-4.1
from 8-K 17 pages Pre-Funded Common Share Purchase Warrant Sophiris Bio Inc. Warrant Shares: Initial Exercise Date: ___, 2019 Issue Date: ___, 2019
12/34/56
EX-4.10
from 10-Q 11 pages Warrant to Purchase Common Shares
12/34/56
EX-4.10
from S-3 16 pages Sophiris Bio Inc. and , as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of [__], 20___ Sophiris Bio Inc. Form of Preferred Share Warrant Agreement
12/34/56
EX-4.9
from S-3 16 pages Sophiris Bio Inc. and , as Warrant Agent Form of Common Share Warrant Agreement Dated as of [__], 20___ Sophiris Bio Inc. Form of Common Share Warrant Agreement
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Sophiris Bio Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Sophiris Bio Inc
12/34/56
EX-4
from S-3 24 pages Sophiris Bio Inc. and , as Warrant Agent Form of Preferred Share Warrant Agreement Dated as of [__], 20___ Sophiris Bio Inc. Form of Preferred Share Warrant Agreement
12/34/56
EX-4
from S-3 23 pages Sophiris Bio Inc. and , as Warrant Agent Form of Common Share Warrant Agreement Dated as of [__], 20___ Sophiris Bio Inc. Form of Common Share Warrant Agreement
12/34/56
EX-4
from 10-Q 11 pages Warrant to Purchase Common Shares
12/34/56
EX-4
from 10-Q 11 pages Warrant to Purchase Common Shares
12/34/56
EX-4.1
from 8-K ~10 pages Registration Rights Agreement
12/34/56
EX-4.7
from S-1/A 36 pages Registration Rights Agreement by and Among Warburg Pincus Private Equity X, L.P., Warburg Pincus X Partners, L.P., and Protox Therapeutics Inc. Dated as of November 19, 2010
12/34/56
EX-4.1
from S-1/A 2 pages C0000000230 M 104598 Security Instructions on Reverse Voir Les Instructions De Securite Au Verso Number 00000000 CSAE_WIP_XCXQ_C02.MTL.PULLS/000001/000001/I Shares ****0********* *****0******** ******0******* *******0****** ********0***** Cusip 83578q209 Isin Ca83578q2099 See Reverse for Certain Definitions Sophiris a British Columbia Company This Certifies That Specimen
12/34/56
EX-4.8
from S-1 36 pages Registration Rights Agreement by and Among Warburg Pincus Private Equity X, L.P., Warburg Pincus X Partners, L.P., and Protox Therapeutics Inc. Dated as of November 19, 2010
12/34/56
EX-4.7
from S-1 160 pages Investment Agreement by and Among the Purchasers Named Herein and Protox Therapeutics Inc. September 28, 2010
12/34/56
EX-4.6
from S-1 12 pages Warrant to Purchase Common Shares
12/34/56
EX-4.5
from S-1 12 pages This Warrant and the Shares Issuable Hereunder Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Act”), or the Securities Laws of Any State And, Except and Pursuant to the Provisions of Article 5 Below, May Not Be Offered, Sold or Otherwise Transferred, Pledged or Hypothecated Unless and Until Registered Under Said Act and Applicable State Securities Law Or, in the Opinion of Legal Counsel in Form and Substance Satisfactory to the Issuer of These Securities, Such Offer, Sale or Transfer, Pledge or Hypothecation Is Exempt From Registration
12/34/56
EX-4.4
from S-1 15 pages Protox Therapeutics Inc. Warrant
12/34/56
EX-4.3
from S-1 15 pages Protox Therapeutics Inc. Warrant
12/34/56